| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 4.814 | 8.337 | 8.288 | 8.508 | 7.696 | 9.814 | 12.537 | 10.870 |
| Total Income - EUR | - | - | 4.814 | 8.337 | 8.288 | 10.417 | 7.786 | 9.814 | 12.655 | 10.891 |
| Total Expenses - EUR | - | - | 2.179 | 3.912 | 2.403 | 6.738 | 6.488 | 6.527 | 11.158 | 12.985 |
| Gross Profit/Loss - EUR | - | - | 2.635 | 4.425 | 5.885 | 3.679 | 1.297 | 3.288 | 1.497 | -2.094 |
| Net Profit/Loss - EUR | - | - | 2.491 | 4.175 | 5.636 | 3.424 | 1.071 | 2.999 | 1.221 | -2.375 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Gyne Florimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 5.913 | 4.322 | 2.785 | 3.216 | 934 | 0 | 20.075 | 14.755 |
| Current Assets | - | - | 826 | 2.418 | 6.987 | 10.000 | 7.547 | 4.470 | 4.864 | 2.301 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 176 | 172 | 207 | 62 | 270 | 916 | 851 |
| Cash | - | - | 826 | 2.242 | 6.815 | 9.793 | 7.485 | 4.200 | 3.948 | 1.450 |
| Shareholders Funds | - | - | 2.535 | 4.218 | 9.773 | 7.482 | 1.119 | 4.122 | 1.269 | -2.327 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 4.204 | 2.522 | 0 | 5.642 | 7.362 | 348 | 23.670 | 19.382 |
| Income in Advance | - | - | 0 | 0 | 0 | 91 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Gyne Florimed S.r.l.